Hey, devs. I hope that the business will perform all that has been target.

I understand that these coins need to be kept in your purse for a long time, because now the coins are worthless, although I thought that the price at the exit would be high

Hey there kubori102

I'm afraid that Shivom won't attend this event.
If the core team of Shivom will attend any event, we will let you know.

We now haven't newcomers in general, KuCoin is a good one, even with that their forced KYC/AML policy. But we can not do anything without new money on the market.

Shivom has created what it calls a Unique Global Genome ID, designed to allow providers and researchers to more easily work with precision data and give patients ownership of their genomic information.

https://medium.com/@projectshivom/shivom-partners-with-singularitynet-for-strengthening-genomics-medical-research-and-advanced-3acd829f8e40

Recently thet announced partnership with Singularitynet to make this process more faster and bring innovatory into this field. They have very clear direction with wonderful vision and the progress of this project also vert attractive. Bright future is belongs to this project.

Now that we just wait for the uptrend to happen, investors are likely to return to the market and OMX will probably increase its real value. I personally believe in this partnership and there is certainly more information that can make many investors return to this ecosystem.

I would ask the core team to see if there's a way an explanation can be made other than using the roadmap as you suggested.
But I want to assure you that project shivom is bigger than India and so it would definitely expand to various parts of the world.

Shivom is one of its kind unique and empowering project which will enable DNA data donors to collaborate with revolutionary changemakers in biotechnology, healthcare industry, and government-ordained research institutes and contribute to an unprecedented era of medical marvels. Their highly secured blockchain technology empowers DNA/ Genome donors with full control over DNA information while enabling them to earn rewards in wilful exchange of genomic information with third parties.